Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN13837 in Acute Ischemic Stroke
NCT02258880Phase 2Withdrawn
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sun13837 in ischemic stroke, sponsored by Daiichi Sankyo Co., Ltd.. Planned start Sep 2014; status: withdrawn.
02
Drugs
sun13837
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02258880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02258880.